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Abstract
We present a new approach to the handling and interrogating of large flow cytometry data where cell status and function
can be described, at the population level, by global descriptors such as distribution mean or co-efficient of variation
experimental data. Here we link the ‘‘real’’ data to initialise a computer simulation of the cell cycle that mimics the evolution
of individual cells within a larger population and simulates the associated changes in fluorescence intensity of functional
reporters. The model is based on stochastic formulations of cell cycle progression and cell division and uses evolutionary
algorithms, allied to further experimental data sets, to optimise the system variables. At the population level, the in-silico
cells provide the same statistical distributions of fluorescence as their real counterparts; in addition the model maintains
information at the single cell level. The cell model is demonstrated in the analysis of cell cycle perturbation in human
osteosarcoma tumour cells, using the topoisomerase II inhibitor, ICRF-193. The simulation gives a continuous temporal
description of the pharmacodynamics between discrete experimental analysis points with a 24 hour interval; providing
quantitative assessment of inter-mitotic time variation, drug interaction time constants and sub-population fractions within
normal and polyploid cell cycles. Repeated simulations indicate a model accuracy of 65%. The development of a simulated
cell model, initialized and calibrated by reference to experimental data, provides an analysis tool in which biological
knowledge can be obtained directly via interrogation of the in-silico cell population. It is envisaged that this approach to the
study of cell biology by simulating a virtual cell population pertinent to the data available can be applied to ‘‘generic’’ cell-
based outputs including experimental data from imaging platforms.
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Introduction
Multiparameter flow cytometry is widely used to study the cell
cycle and its perturbation in the context of both basic research and
in routine clinical analysis [1–6]. Such analyses may use a wide
range of fluorescent reporters that correlate to the expression of
key molecular components of the cell cycle, such as cyclins and
cyclin dependent kinases (CDK), [1] or quantify DNA content [5].
Regardless of the particular fluorophores used the quantitative
methodology and the ensuing synthesis of biological knowledge is
based on statistical analyses of the experimental data sets. For
single variable distributions these may include calculations of
moments of increasing orders to provide the mean, variance,
skewness etc. or cumulative indices such as the Kolmogorov-
Smirnov (K-S) test [7–9]. More complex, multi-variate approaches
may involve discriminant function, cluster or principal component
analysis in an n-dimensional space [10–12]. In all of these
approaches there is a common procedural thread: acquisition of
data is followed by a statistical parameterisation of the measure-
ment set to which biological form or function can be correlated. In
this work, we present an alternative, based on computational
simulation of the experiment. A stochastic simulation of the cell
cycle dynamics within a large population is initialised with
reference to a flow cytometry data set and then evolved, using
evolutionary computer algorithms, with assessment of fitness
measures derived from comparisons to subsequent data sets. The
cell-cycle information is then read directly from the in-silico
populations.
The development of a simulated cell population approach has
been driven by a requirement to track the evolution of large
numbers of cells over multiple generations through the cell cycle
and provide a means to track progression of both the whole cell
population and distinct sub-groups [13,14]. This is in the context
of mapping the heterogeneity of cell cycle response to perturbation
events e.g. effects on cell proliferation of anticancer therapeutics
designed to block cell division. In this report we present the
conceptual basis of this simulated cell cytometry and detail of the
methodology adopted. To demonstrate the application of the
technique and validate its potential we use it to quantify cell cycle
perturbation in a tumour cell line by a topoismerase II inhibitor
which causes endocycle routing in the late cell cycle.
The aim of the simulation is to predict the dynamic evolution of
a large population of virtual cells (vcells) through a life cycle
corresponding to that prescribed by their real-life counterparts (as
reported via flow cytometry experiments). Furthermore, the model
seeks to account for perturbations in the cell cycle progression of
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the virtual population (vpopulation). The spatial position of the
vcells within the cell cycle is initially determined from a real flow
data set. From this information, each vcell is assigned a temporal
position within the mean inter-mitotic time (mIMT), allowing cell
cycle events such as DNA replication and cell division to be
stochastically predicted. After the vpopulation has evolved for a
given period, they may be compared with a further experimental
data set to enable important simulation parameters, governing
their evolution, to be optimised and constrained so that
correlations between the respective data sets are maximised.
Standard approaches to studying cell cycle involve statistical
analysis of distributions either 1D involving nuclear content
reporters [5] or 2D when further cell cycle molecular reporters are
also included [1,15]. Thus these are inherently ‘whole population’
measures and can only describe cell variability via global
parameters such as the standard deviation from the mean. Whilst
automated analytical approaches have been developed in order to
reduce user subjectivity [16–18] the majority of flow analyses still
involve user-defined gating of the as-measured data set to identify
and segment a sub-population of cells. Subsequent mapping of this
population onto 2D dot plots of fluorescence provides temporal
snapshots (typically with a 24 hour sampling period) and further
partitioning of cells to different compartments, G1, S, G2/M
within normal and polypoid cycles (see Figure 1(a)). These
apparent quantitative assessments become inaccurate and, to
varying extent, subjective, as they are based either on user
identification of the various components in the dot plot by fitting of
Gaussian distributions, representing the G1, S, G2/M fractions, to
the DNA content histogram [5]. The challenge of the current
investigation is to adopt a computational approach, where the
analytical and interpretive steps are implemented at the simulated
biology stage and not on the raw data outputs. No new data is
added in this approach and the computer simulations could be
viewed as an elaborate form of data analysis. However, the
methodology does deliver new insight on process, delivering a
continuous simulation of the dynamic evolution of the cellular
system between fixed sampling points. In this respect, it provides a
physical validation when applying various hypotheses to interpret
the experimental data. It also goes some way to visualising the
variation between individual cells that gives rise to biological
heterogeneity as the stochastic simulation delivers a report on
population dynamics in which each and every cell can be tracked.
Figure 1. Plots indicating cell pathways through the cell cycle. (a) A schematic indicating cell cycle routing of cells treated with ICRF-193 in
fluorescence space (GFP-cyclin B1 signal as a function of DRAQ5 signal). In control conditions U-2 OS cells divide and remain in normal cycle
(representing the proliferative fraction), with ICRF-193 treatment the U-2 OS cells continue to cycle however they bypass mitosis to enter a polyploid
cycle (p) (representing the non-proliferative fraction). (b) Segmentation of experimental flow cytometry data representing molecular expression and
DNA content used to initialise the CPM. Experimental data at texpt = 0: experiment non-gated data (green and red markers), experimental gated data/
initial virtual population (red markers) and the dashed black line refer to the contour defining the gated data. The solid black line indicates the best
representation of the fitted population (see text).
doi:10.1371/journal.pcbi.1000741.g001
Author Summary
One of the key challenges facing cell biologists today is
understanding the influence of molecular controls in
shaping and controlling cell growth and proliferation.
There is growing recognition that abnormal progression
through the cell cycle and the associated effects on the
growth of cell populations has a major impact on a wide
range of biological and clinical problems, including:
tumour growth, developmental control, origins of chro-
mosomal instability and drug resistance. Multiparameter
flow cytometry is frequently used to assess proliferation
dynamics of cellular populations using fluorescent report-
ers generating large data sets that can inform simulation
models. We have developed stochastic computing ap-
proaches allied to evolutionary algorithms to produce
simulated cell populations—providing a new approach to
the analysis of real multi-variate data sets obtained by flow
cytometry. The methodology delivers new insight on
biological processes in delivering a continuous simulation
of the dynamic evolution of a cellular system between
fixed sampling points, hence, converting static data into
dynamic data revealing the effective traverse of the cell
cycle, restriction points and commitment gateways. The
approach also permits the visualisation of the variation
between individual cells reflecting biological heterogene-
ity and potentially Darwinian fitness, given that the
simulation delivers a report on population dynamics in
which each and every cell can be tracked.
Virtual Cell Evolution through the Cell Cycle
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Materials and Methods
Experimental procedures
Experimental data is obtained using well-established bi-variate
cytometric methods for study of the cell cycle: U-2 OS (ATCC
HTB-96) cells were transfected with a G2M Cell Cycle Phase
Marker (GE Healthcare, UK), yielding stable expression of a
GFP-cyclin B1. This provides a green fluorescence signal the
intensity of which correlates to position in the cell cycle with a
minimum signal at G0 and a peak during the G2/M phase. [19].
The culture was maintained under G418 selection in McCoy’s 5a
medium supplemented with 10% foetal calf serum (FCS), 1mM
glutamine, and antibiotics and incubated at 37uC in an
atmosphere of 5% CO2 in air. To obtain fluorescence read-out
of DNA content an anthraquinone derivative, DRAQ5TM
(20 mM Biostatus Ltd., UK) was used [14]. This binds to DNA
providing a fluorescence intensity that can be related to DNA
content and thus it reports on cell cycle progression through the S
phase to G2/M (.4N) or, in the presence of external perturbing
agents, progression through polyploid states as the mitotic stage is
by-passed [20] (see Figure 1(a)). To obtain a model system in
which we can test the simulated cell population approach we
have used a cell division by-pass agent: ICRF-193 [bis(2,6-
dioxopiperazine)], a kind gift from Dr A.M. Creighton (ICRF,
London, UK). This is a reversible catalytic inhibitor of
topoisomerase II that blocks the ability of the enzyme to resolve
interlinked DNA replication products [21]. The decatenation of
chromosomal replication products is vital for the completing of
segregation and hence normal division. ICRF-193, was prepared
in DMSO at 2 mg/ml and used at a peak concentration of 2 mg/
ml (equivalent to 7.2 mM).
To determine the cell population distribution of fluorescence
intensity a FACScan flow cytometer was used (Becton Dickinson
Inc., Cowley, UK) which was equipped with an air-cooled argon
ion laser (with 488 nm output only). GFP-cyclin B1 data was
collected using a 30 nm bandpass emission filter centred at
530 nm and the DRAQ5 signal with a 670 nm long pass filter.
CELLQuest software (Becton Dickinson Immunocytometry Sys-
tems) was used for data acquisition. Flow cytometric analysis was
used sample sets of 10,000 cells and the data presented represents
the signal peak height. Typically, tracking of the population was
carried out at 24 hour intervals.
Virtual cell populace simulation
The computer simulation consists of two principal components;
a cell population model (CPM) and an evolutionary algorithm -
Differential Evolution (DE) [22]. The CPM generates a virtual
population of cells (vcells), which is initialised using a flow data set.
The vpopulation is then evolved and compared to a subsequent
flow data set. The CPM evolves each vcell and generates any cell
cycle processes deemed relevant to explain the laboratory
experiment. A DE algorithm is employed to optimise important
ensemble parameters used in the CPM e.g. cell cycle time,
enabling the vpopulation to be evolved such that it maximises
correlation with the data. A detailed description of the cell
population simulation, complete with a full account of the various
numerical algorithms and techniques used is given in Text S1. A
brief outline of the main components of the cell population model
is given in the following sections with reference to the simulation
flowchart shown in Figure 2. All numerical algorithms have been
written in the MATLAB environment (MathsWorks UK);
fragments of pseudo-code for important aspects of the CPM are
given in Text S1.
Cell population model - initialisation
The vpopulation is initialised by reference to a gated 2D flow
cytometric data set composing of the cell cycle reporter cyclin B1
(GFP-cyclin B1) and DNA content determination (DRAQ5) (see
Figures 1(b) and S1). The data is gated using a simple cell density
cut-off technique, where a region is labelled active if its cell density
is above a set threshold, (see Text S1). Cells within a contour
encapsulating the gated fraction serve to initialise the vpopulation
position in the intensity space. The same gating procedure (and
threshold value) is also applied to subsequent experimental data
sets at later time points. More sophisticated gating techniques
could be applied such as the expectation-maximisation algorithms
presented by Boedigheimer et al [18]; however, this simple
approach is adequate to establish the validity of our methodology.
The gated data is now used to initialise the fluorescence
intensities of the modelled cell population, which correspondingly
inherits the biological variation seen in Figure 1(b) (each gated
data point initialises one cell). The temporal position of each of the
virtual cells within the cell cycle is unknown as the flow data
(consisting only of only fluorescence intensities) contains no direct
cell cycle time information. The time-based information, necessary
to model the cell cycle dynamics, is extracted from the intensity
signal of the biological markers obtained from the experimental
data (see Text S1). The first approximation to assigning a time to
each vcell is obtained by considering the DRAQ5 fluorescence
intensity, the histogram of which is shown in Figure 3(a). In our
approach, we use the DRAQ5, nuclear content indicator to
position each vcell in the cell cycle making the following
assumptions (i) the vcells are randomly distributed throughout
their cycle and (ii) that their DRAQ5 signal is monotonically
increasing through the cell cycle as the nuclear content is
duplicated. This infers that the minimum and maximum DRAQ5
intensities correlate to the start and finish of the cell cycle and
allows us to assign relative position in time to each vcell (see Text
S1 and figure S2). The experimental dataset for DRAQ5 intensity
is sorted into ascending order and fitted with a polynomial
function (see Figure 3(b)). Because of the inherent digitisation
produced by data binning, of the measured intensity, by a flow
cytometer several cells will be recorded with the same DRAQ5
signal. The intensity sorting procedure assigns increasing sort
indices to vcell sets with the same intensity (i.e. all cells within a
given bin) the median index value is therefore used when
implementing the polynomial fit (see inset in Figure 3(b)). Finally,
the polynomial x-axis values are scaled to a range of zero to the
inter-mitotic time (IMT - time between successive mitotic events),
this gives an absolute time for each cell within its cycle. To relate
the GFP signal to cell cycle time the intensity for each cell is
plotted against the cell number index obtained from the DRAQ5
sort procedure, again fitted with a polynomial and scaled to give
an x-axis running from 0 to the same IMT value (Figure 3(c)). The
use of a stoichiometric nuclear content marker (such as DRAQ5)
to estimate DNA content and hence cell cycle position is well
established and both deterministic and stochastic models have
been used previously to obtain continuous temporal descriptions
[23–25]. Our approach differs from the previous studies in that
through the creation of the virtual cell population we model at the
level of single cells rather than using population level parameters.
The two fitting polynomials describe the evolution of the
fluorescence intensities from cell birth to division as a function of
time and are used to produce a median path through the cell cycle
shown as the solid black line in the 2D GFP-DRAQ5 intensity plot
displayed in Figure 1(b). It is obvious from the plot that many of
the cells lie some distance from the median line this is due to
natural variability in the measured signals caused by heterogeneity
Virtual Cell Evolution through the Cell Cycle
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in reporter loading, noise, variation in collection efficiency etc.
Each individual vcell is therefore assigned a cell cycle time by
choosing a point on the 2D polynomial median line, that
minimises the sum difference of the DRAQ5 and GFP intensity
values (see Text S1 and figure S3). Therefore vcells at the same
point within the cell cycle will display a heterogeneity in
fluorescence signal value (corresponding to the width of the
population plot in x and y-directions in Figure 1(b). Therefore, to
calculate the time-dependent trajectory of each vcell through the
2D intensity space we update the DRAQ5 and GFP intensity
values using the median line as time is incremented (see Text S1).
To summarise, the experimentally measured data is used to
establish a virtual cell population with exactly the same
heterogeneity in fluorescence signal as seen in the experiment.
This vpopulation is then evolved within a stochastic simulation
allowing for variability in fluorescence intensity and IMT using a
pair of polynomial functions that describe the cell cycle
dependence of the signal, i.e. the absolute fluorescence is stochastic
but the time evolution function is the same for all cells.
Cell population model - evolution
Once initialised each member of the population has three
discriminating properties corresponding to: (i) a time in the cell
cycle, (ii) DRAQ5 fluorescence intensity and (iii) GFP-cyclin B1
levels. In order to mimic DNA synthesis and replication, a
supplementary parameter, DRAQ5DNA2, is required; DRAQ5DNA2
details the DRAQ5 magnitude at which each vcell has doubled its
DRAQ5 intensity (see Text S1 and figures S4 and S5). The CPM
directly relates this to the point at which a real cell has doubled its
DNA content, i.e. a phase transition to G2. The value of
DRAQ5DNA2 is deduced by calculating the initial DRAQ5 intensity
of each vcell at the start of the cell cycle (see Figure 1(b), black curve),
which from the above is estimated at the effective intensity value just
after a mitotic event, then assessing the time at which this initial
intensity doubles using the polynomial functions shown in
Figures 3(b) and (c).
Monitoring of the simulated DRAQ5 intensity then allows
identification of cells that have multiplied their DNA content
allowing placement of each into the following sub-groups: normal
Figure 2. Flowchart indicating the main steps of the cell population model (CPM).
doi:10.1371/journal.pcbi.1000741.g002
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cycle – DNA index, DI = 2N (G1) or 4N (G2/M); polyploidy
cycle - DI = 4Np (G1p) or 8Np (G2p/Mp). Once vcells have entered
the G2/M phase the probability of them entering the M phase and
undergoing cell division is calculated. This is achieved using a
simple stochastic decision process [13], where we define a
cumulative Gaussian probability distribution which scales between
0 and 1, defined in terms of a mean inter-mitotic time, with an
associated standard deviation, over the cell cycle time. Both these
parameters are to be optimised via the evolutionary algorithm to
best fit the second set of flow data. At each time step a random
number, uniformly distributed in the interval [0 1] is generated
and is compared with the cumulative probability distribution value
at that time. If the random number is less than the probability
distribution value calculated then mitosis is deemed to occur and
the simulation generates two daughter cells at t = 0 in G1/S with
the DRAQ5 and GFP-cyclin B1 associated with the parent cell.
Otherwise, the cell remains in the G2/M phase for re-analysis at
the following time step, which will increase both of its intensity
coordinates resulting in a higher probability of mitosis (the
cumulative Gaussian distribution tends to 1 with increasing time).
The implementation of this mitotic variability produces further
heterogeneity in the IMT of the individual vcells.
The cell population model is defined by a set of parameters
specific to the flow cytometry experiment conducted. Optimisation
of the fit between simulation and experiment is dependent upon
selection and minimisation of the population variables, in our case:
the mean inter-mitotic time, its standard deviation and a
parameter detailing the presence of a drug in the vpopulation.
There are several different methods, which could be used to
determine the best fit to the experimental data; we choose to use a
differential evolutionary technique to optimise these cell cycle
parameters. The quality of fit associated with a set of CPM
parameters is determined by calculation of the ratio of evolved
vcells to that measured experimentally within a numerically
deduced gated region. This simple maximisation strategy, works
well for both therapeutically (un)perturbed systems, although
newer versions of the CPM will explore more sophisticated 2D
cross correlative algorithms to infer fitness. Convergence of the
differential evolution algorithm is determined true when the
quality of fit varies by less than 1% over five subsequent
generations (see Text S1).
Results
Cell population simulation
To illustrate the evolution of the vcell population, we generate a
series of snap-shots derived at different temporal intervals (Figure 4 -
green population) demonstrating the simulated intensity dot plot at
6, 12, 18 and 24 hours respectively after initialisation by an
experimental data set. Here, the vcell population has a mean IMT
of 22 hours and an associated standard deviation of 6 hours; a
small subpopulation of vcells can be depicted (red dots) also a
contour (dashed black line) is displayed, indicating the extent of the
gated experimental data set at initialisation. Given that the cells in
these experiments are randomly distributed within their cycle and a
statistically relevant data set is sampled the acquired plots appear
identical for a control sample with an unperturbed biology. The
advantage of the simulated population approach is therefore
evident in Figure 4, as a discrete sub-set of cells is identified and its
dynamics tracked over a period of time. Despite using a single
experimental sample information is obtained across the whole of
the cell cycle due to the assumption of random temporal
distribution. The fundamental insight gained here is the adoption
of a simulated cell approach and subsequently the visualisation of
Figure 3. Comparison of traditional analyses of static flow
cytometric data and to that used to develop dynamic data
analysis. (a) Displays the fluorescent frequency histogram of the
DRAQ5 intensity, plots (b) and (c) graphically illustrate how the median
DRAQ5 and GFP cyclin-B1 fluorescence signals vary as a function of a
normalised intermitotic time (light grey and blue lines respectively.
Insert: plot (b) - magnification of the polynomial fit to the frequency
histogram of the DRAQ5 intensity.
doi:10.1371/journal.pcbi.1000741.g003
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the temporal dimension encoded in the fluorescence intensity
distributions.
Cell cycle perturbation and cell cycle rerouting to
polyploidy
To test the ability of the simulation to capture more complex
dynamics associated with aberrant cell cycle progression and
variance of response across sub-populations a cell cycle perturba-
tion experiment was undertaken using a mitotic by-pass agent
ICRF-193. Cells treated with this agent progress through multiple
replication cycles without undergoing mitosis, therefore doubling
DNA content [21]. This leads to an evolving polyploid population
that is identified using the nuclear dye, DRAQ5 to obtain an
optical read-out of DNA content. Perturbation of the cell cycle and
rerouting of cells in this manner provides a system in which the
population dynamics of diverted sub-groups within the normal and
polyploidy cycles can be analysed. The challenge for the cell
population simulation is to track the inter-related pharmacody-
namics, taking full account of the detailed evolution of the
accompanying fluorescence data.
Experimental outputs
A block and chase experiment was conducted in which cells
were continuously treated with ICRF-193 for 24 hours (Figure 5(a–
c)). A 2D dot plot of the cell cycle (GFP-cyclin B1) and nuclear
content (DRAQ5) reporters at the 24 hour time point shows a sub-
population of cells with low GFP-cyclin B1 expression and a DNA
index of 4N i.e. polyploid cycle cells in the G1/S phase
(Figure 5(b)). Compared to control conditions, where all cells
were engaged in the normal cell cycle. Following the 24 hour drug
treatment with ICRF-193, wash-out allows cells to further cycle
unperturbed under normal conditions for a further 18 hours
(including cell division). ICRF-193 is a reversible topoisomerase II
blocker and so removal of this agent enabled the sub-population of
cells within G2/M of the normal cycle to be routed back into
normal cycle (i.e. to G1/S). Hence, the 42 hour data shows two
distinct population groups describing cells within the normal and
polyploid cycle (Figure 5(c)).
Model outputs
To include the effect of the ICRF-193 in the CPM we include a
further optimisation parameter Nbp, which describes the fraction of
vcells that have doubled their DNA content (G2/M phase) but
have bypassed mitosis. These are selected stochastically and
inhibited from undergoing cell division when under drug ‘dosing’
conditions. This assignment is undertaken at each time step, until
the required percentage of vcells in the population have by-passed
mitosis. In the drug ‘wash-out’ conditions, the reduction in Nbp is
modelled with a half-life, t1/2, corresponding to the temporal
persistence of the drug-induced perturbation. Thus depending on
drug administration or wash-out the CPM has three optimisation
variables to be minimised through the evolutionary methods
described previously. The comparison of real (red population
displayed in Figure 5(b)) and vcell populations for selection of the
variable parameter values is made 24 hours after initialisation.
The optimised vcell population together with the real data contour
is shown in Figure 6(a) together with a contour illustrating the
position of the initial data set. The simulation clearly captures the
key features of the population evolution and given the stochastic
nature of both real and virtual cell populations they are well
correlated. At this point, following 24 hours of continuous drug
treatment, there are large fractions of 4n cells in the normal and
4np polyploid phases as well as a sub-population of polyploid cells
progressing to 8np phase. A small population sub-set (located
within the black dashed contour in Figure 6(a)) represents the vcells
yet to be influenced by the drug. As mentioned above, at each
Figure 4. Model simulation to track a virtual sub-population (red markers) of vcells through the cell cycle at (a) 6 hours (b) 12 hours
(c) 18 hours and (d) 24 hours. Note: the overall vcell population has a mean intermitotic time of 22 hours and an associated standard deviation of
6 hours.
doi:10.1371/journal.pcbi.1000741.g004
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discrete time throughout the simulation the vcells are stochastically
tested to see if they have been drug treated, hence, a finite time
must elapse before all vcells can be influenced by the action of the
drug.
The vcell dynamical parameters corresponding to the fits shown
in Figure 6 are indicated in Table 1. In the presence of the drug
the simulation indicates a mean inter-mitotic time of 36 hours with
a standard deviation of 4 hours. In comparison, the IMT value
from fitting to a control set of data is 2264 hours. Multiple runs
(1,000 simulations of the experimental data) of the model indicate
that the variation in the tabulated values, due to stochastic
variation and evolutionary selection, is less than 5%. The
prediction of an extended IMT within drug treated cells is in
agreement with previous studies on the effects of ICRF-193,
showing delays in progression to the mitotic phase plus extension
in the duration of mitosis once initiated. Although, the CPM
cannot elucidate on the persistence of individual phase duration it
does accurately estimate their combined effect.
During the chase phase of the assay subsequent to drug wash-
out, the simulation evolves from 24 to 42 hours in a similar
manner to that above, with the difference that the Nbp parameter is
indirectly optimised using a half-life to describe its temporal decay;
i.e. the fraction of vcells that retain drug-induced division-bypass is
Nbp tð Þ~Nbp t~24hrsð Þe{T1=2t where T1=2~ln 2ð Þ

t1=2 and t is the
time since wash out. The intensity coordinates of the vpopulation
at 42 hours after ICRF-193 washout are displayed in Figure 6(b).
The simulation has captured the important features of both the
normal and polyploid cycle dynamics. That is, there is a significant
sub-population of vcells in each of the four DNA indexed phases.
For the 2D fit shown in Figure 6(b) the simulation uses a mean
inter-mitotic time of 2267 hours respectively. This agrees
remarkably well with that measured through microscopic
Figure 5. Endocycle routing with ICRF-193 (a), (b) and (c) indicate experimental data (green markers), gated sub-set (red markers)
and a contour of the gated data (dashed black line) at 0, 24 and 42 hours respectively.
doi:10.1371/journal.pcbi.1000741.g005
Figure 6. Simulated vpopulation at (a) 24 and (b) 42 hours respectively. The red shaded areas are virtual cells that lie within the respective
experimental gated contours shown in Figures 6(b) and (c), the green shaded points are simulated data lying outside of these contours. Also
indicated is the gated, time zero experimental data set contour (black dashed line).
doi:10.1371/journal.pcbi.1000741.g006
Virtual Cell Evolution through the Cell Cycle
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techniques for an unperturbed real populace. Furthermore, the
simulation gives an insight to the temporal persistence of the drug
on the virtual population, indicating that a significant sub-
population retain or are committed to the division bypass over
the course of a few hours following wash-out. The fact that an
effective continuum of intensities straddling the 4np and 8np
phases in both real and virtual populations is evident reinforces the
simulation result which highlighting of temporal persistence of
ICRF-193 post washout. The evolution and perturbation of the
vcell population is shown in Video S1.
The continuous population dynamics provided by the simula-
tion are shown in Figure 7. At the initialisation point (t = 0 hours)
we see that a significant fraction of vcells are present in the 2n
phase compared to that in the 4n phase (blue and green curves
respectively), ,4:1 ratio. Over the first 24 hours, the drug
perturbation re-routes cells from the normal into the polyploid
cycle. Thus, the 4n population is stable as equal numbers of move
in and out of it producing linearly decreasing 2n and linearly
increasing 4np sub-populations. The percentage of mitotic-bypass
cells therefore increases over time, but due to dynamical
constraints and the optimised mean inter-mitotic time of 36 hours,
this does not reach 100% (maximum of ,85%) before washout.
The vertical dotted line in Figure 7 indicates the initiation of the
washout phase of the simulated experiment. Following drug
washout at 24 hours the fraction of mitotic-bypass vcells decreases
exponentially with an optimised half-life of 3 hours, thus it takes
the full 18 hours following drug removal to achieve something
near to normality. This same dynamic inevitably affects the re-
creation of a 2n population. This gives an insight to the temporal
persistence of drug on the vpopulation indicating that a sub-
population retains the bypass commitment for a few hours post
washout.
Discussion
The use of stochastic computing approaches plus evolutionary
algorithms to evolve a simulated cell population provides a new
approach to the analysis of multi-variate data sets obtained by flow
cytometry. In using this simulated biology process to analyse cell
cycle perturbation we have obtained detailed information cell
cycle time and the detailed dynamics of cell division and
proliferation. Furthermore, we have shown that a subpopulation
or cohort can be defined and tracked throughout the time course
of the experiment without the need for further molecular markers,
this can be essentially viewed as an in silico representation of the
pulse chase experimental methods such as those incorporating
two-parameter flow cytometry analysis: with DNA content and
BrdUrd [26]. When applying the technique to drug-treated
populations the pharmacodynamic indicators can be tracked and
sub-populations within normal and polyploid cycles differentiated.
Further, the temporal continuity inherent in the computational
assessment also highlights details un-resolvable in the experimental
sampling, such as cell cycle traverse (inter-mitotic time variation),
cell cycle delays (persistence of drug-induced effects) and has also
identified the occurrence and location of cell cycle restriction
points, which with additional molecular mapping can be further
defined [27]. Also, the simulated experiment permits individual in
addition to (sub)population cell tracking allowing single cell lineage
tracking and the ensuing generational patterns and relationships to
be continually analysed. This is a systems approach to whole
tumour population evolution leading to lineages, in contrary to
tracking individual lineages and extracting a global population
response [28]. We envisage that this approach would be much
more easily applied to a screening approach appropriate for
sampling tumours both in vitro and in vivo.
In this initial implementation of the technique, we use a cell
cycle marker that reports on relative cycle time and a nuclear
marker which allows us to discriminate between normal and
polyploid cell populations, therefore no further information of the
intricate details of the cell cycle (apart from mean IMT
distribution) can be deduced. In this respect, the simulated cell
methodology provides a framework, describing the relationships
between cells within a population, at a system level i.e. in the
context of progression through a unitary cycle with associated
genetic replication and cell division. Importantly this structure can
enhance existing approaches by linking detailed molecular level
models of cellular evolution through specific cell cycle phases
[26,27,29] to cell heterogeneity and its influence on population
level dynamics.
We have adopted an approach of minimised complexity in
order to clearly demonstrate the concept without the obfuscations
of detailed algorithm structures and data filtering. A simple dot
density cut-off filter is applied to gate the data, the number of
variable parameters within the genetic algorithms is reduced to a
minimum of three and goodness of fit assessed by a straightforward
maximisation of simulated cells within an experimental data
contour. Whilst future work will explore the potential of more
sophisticated computational techniques, the simple conceptual
base presented here already provides automated, objective data
analysis that encapsulates the fundamental biology and delivers
Figure 7. The normalised virtual cell count throughout the
time-course of the experiment. The blue, green, red and yellow
curves indicate the fraction of virtual cells in the 2n, 4n, 4np and 8np
phases of the cell cycle respectively. In addition, the fraction of virtual
cells drug blocked throughout the simulated experiment is indicated by
the black curve.
doi:10.1371/journal.pcbi.1000741.g007
Table 1. Optimised parameter values of the vcell population.
Parameter
mIMT
(hours)
sIMT
(hours)
Nbp
(%)
t1/2
(hours)
Drug treated (0–24 hrs) 36 6 99 -
Wash-out (24–42 hrs) 22 7 - 3
doi:10.1371/journal.pcbi.1000741.t001
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statistically robust results. Given the stochastic nature of the
simulation it could be argued that a statistical approach should be
maintained and increased simulation runs be used to acquire
added certainty rather than increased model complexity. The
large data sets collected in flow cytometry and the stochastic
variation associated with biological systems naturally lead to
statistical analysis techniques for data interpretation [23–25].
These have proven to be powerful tools in cell biology, however
when focussing on individual cell behaviour and heterogeneity
expressed at the single cell level the integrative measures of
statistics are limiting. The development of a simulated biology,
twinned to a real cell population, by fitting experimental data sets,
maintains the statistical relevance and provides discrimination via
individual cell recognition. The creation of in-silico cells brings the
potential for interpolation and extrapolation thus a continuous
temporal report of complex population dynamics can be produced
from discrete measurements and cellular behaviour predicted
beyond the limited time frame imposed by experiment and
environment. The temporal continuity inherent in the computa-
tional assessment also highlights details of the pharmacodynamics,
un-resolvable in the experimental sampling, such as inter-mitotic
time variation and persistence of drug-induced effects. Perhaps the
most beneficial aspect of the simulated cell approach is its ability to
provide direct knowledge of biological state allowing a computa-
tional systems approach to inform the biology. This contrasts with
traditional flow analysis, which provides information that is
primary in relation to data but secondary in relation to cells; i.e.
a choice can be made between direct data analysis with
interpretation to translate to cell behaviour or direct read-out of
cellular information from a data-directed simulation. By ensuring
interoperability of the modelling algorithm with experimental
cytometry outputs, the simulation provides emergent features of
the cell cycle and the functional operation of molecular restrictions
and checkpoints; providing further the foundation for considering
the evolving asymmetric and symmetric patterns of a dynamic
cellular system.
Supporting Information
Text S1 Information (detailed information, figures and movies)
will be given a leading ‘S’ to designate that they are present within
Supplementary Information.
Found at: doi:10.1371/journal.pcbi.1000741.s001 (0.22 MB
DOC)
Figure S1 Flow cytometry data set indicating the DRAQ5 and
GFP-cyclin B1 fluorescence intensities of a measured cell
population. This plot highlights the raw data (grey) and the
subsequent gated fraction (red); also, the three principle sub-
fractions present within the raw data are numerically labelled.
Found at: doi:10.1371/journal.pcbi.1000741.s002 (1.78 MB EPS)
Figure S2 Fluorescence intensity plot of the normalised
vpopulation; vcells highlighted in red refer to those with the
lowest normalised DRAQ5 values.
Found at: doi:10.1371/journal.pcbi.1000741.s003 (2.79 MB EPS)
Figure S3 Plot indicating the curve v’s over the cell cycle
interval [0 IMT], and the vpopulation, 3 members of which have
been highlighted (yellow markers) with DRAQ5 and GFP intensity
differences (red arrows) corresponding to equations [S2.3.2].
pDRAQ(t)pGFP(t)
Found at: doi:10.1371/journal.pcbi.1000741.s004 (2.59 MB EPS)
Figure S4 Figure indicating location of the roots (yellow
markers) between the median intensity line and linear functions
(that enclosed by red ellipses) describing evolution of DRAQ5 and
GFP intensity coordinates as a function of time.
Found at: doi:10.1371/journal.pcbi.1000741.s005 (2.61 MB EPS)
Figure S5 Intensity plot highlighting the properties of three
randomly chosen cells. These properties include: their vcells
intensity coordinates at both t and t marked in yellow and red
respectively and their corresponding intensity trajectory through
their cell-cycle (solid black lines). vE=0t = 0
Found at: doi:10.1371/journal.pcbi.1000741.s006 (3.00 MB EPS)
Video S1 VPopulation simulation
Found at: doi:10.1371/journal.pcbi.1000741.s007 (2.61 MB
WMV)
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